Harrow, Inc. (HROW) stock

HROWNasdaqPharmaceutical PreparationsFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 9, 2026Score 6/30

$30.12+1.82 (+6.43%)

Close on Nov 13, 2026Market cap $1.13BP/E –Yield –

Earnings

Harrow's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report

Mar 1, 2027

Q4 FY2026 · estimated, after the close

Revenue, Q3 FY2026

$99.30M

+38.7% on a year earlier

Adjusted EPS, Q3 FY2026

$0.25

$0.33 a year earlier

Latest guidance

Raised

Nov 9, 2026 · 3 items

Quarterly results

Revenue and earnings per share from each of Harrow's earnings releases, newest first

Quarter	Reported	Revenue	YoY	EPS	Adj. EPS	Source
Q4 FY2026ended Dec 31, 2026	Mar 1, 2027Expected	–	–	–	–	–
Q3 FY2026ended Sep 30, 2026	Nov 9, 2026after the close	$99.30M	+38.7%	$0.25	–	Release
Q2 FY2026ended Jun 30, 2026	Aug 10, 2026after the close	$70.70M	+11.0%	-$0.46	–	Release
Q1 FY2026ended Mar 31, 2026	May 11, 2026after the close	$44.20M	-7.5%	-$0.74	–	Release
Q4 FY2025ended Dec 31, 2025	Mar 2, 2026after the close	$89.10M	+33.4%	$0.17	–	Release
Q3 FY2025ended Sep 30, 2025	Nov 10, 2025after the close	$71.60M	–	$0.03	$0.33	Release
Q2 FY2025ended Jun 30, 2025	Aug 11, 2025after the close	$63.70M	+30.2%	$0.13	$0.24	Release
Q1 FY2025ended Mar 31, 2025	May 8, 2025after the close	$47.80M	+38.2%	-$0.50	-$0.38	Release
Q4 FY2024ended Dec 31, 2024	Mar 27, 2025after the close	$66.80M	+83.7%	$0.24	$0.40	Release
Q3 FY2024ended Sep 30, 2024	Nov 14, 2024before the open	–	–	–	–	Release
Q2 FY2024ended Jun 30, 2024	Aug 7, 2024after the close	$48.94M	+46.1%	-$0.18	-$0.06	Release
Q1 FY2024ended Mar 31, 2024	May 13, 2024after the close	$34.60M	+32.6%	-$0.38	-$0.28	Release
Q4 FY2023ended Dec 31, 2023	Mar 19, 2024after the close	$36.36M	+78.8%	-$0.26	-$0.20	Release
Q3 FY2023ended Sep 30, 2023	Nov 13, 2023after the close	$34.30M	+50.4%	-$0.13	-$0.09	Release
Q2 FY2023ended Jun 30, 2023	Aug 9, 2023after the close	$33.50M	+43.8%	-$0.14	-$0.02	Release
Q1 FY2023ended Mar 31, 2023	May 11, 2023after the close	$26.10M	+18.1%	-$0.22	-$0.03	Release
Q4 FY2022ended Dec 31, 2022	Mar 23, 2023after the close	$20.33M	+0.6%	$0.04	$0.07	Release
Q3 FY2022ended Sep 30, 2022	Nov 14, 2022after the close	$22.80M	+21.9%	-$0.24	-$0.06	Release
Q2 FY2022ended Jun 30, 2022	Aug 9, 2022after the close	$23.30M	–	-$0.23	$0.01	Release
Q1 FY2022ended Mar 31, 2022	May 5, 2022after the close	$22.10M	–	-$0.09	$0.03	Release
Q4 FY2021ended Dec 31, 2021	Mar 10, 2022after the close	$20.20M	–	-$0.27	–	Release
Q3 FY2021ended Sep 30, 2021	Nov 9, 2021after the close	$18.70M	–	-$0.31	–	Release
Q2 FY2021ended Jun 30, 2021	Aug 10, 2021after the close	–	–	–	–	Filing
Q1 FY2021ended Mar 31, 2021	Apr 14, 2021after the close	–	–	–	–	Filing
Q4 FY2020ended Dec 31, 2020	Mar 8, 2021after the close	–	–	–	–	Filing
Q3 FY2020ended Sep 30, 2020	Nov 9, 2020after the close	–	–	–	–	Filing

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Current guidance

Harrow's latest outlook for periods it has not reported yet, compared with what it said before

Metric	Period	Guidance	Before	Change	Given
Adjusted EBITDAnon-GAAP	Q4 FY2026	$33.00M	–	New	Nov 9, 2026
revenue	FY2026	$350.00M – $365.00M	$350.00M – $365.00M	Reaffirmed	Aug 10, 2026
revenue guidance	FY2026	$350.00M – $365.00M	$350.00M – $365.00M	Raised	Nov 9, 2026
Adjusted EBITDAnon-GAAP	FY2026	$40.00M	$80.00M – $100.00M	Lowered	Nov 9, 2026
Adjusted EBITDAnon-GAAP	FY2026	$80.00M – $100.00M	–	New	Aug 10, 2026

Guidance vs results

The last range Harrow gave before each report, against the figure it then reported. Full years add up the four quarters.

Period	Metric	Guidance	Actual	Result
Q2 FY2026	Revenue	$71.00M – $81.00M	$70.70M	Below range
FY2025	Revenue	$270.00M – $280.00M	$272.20MΣ4Q	Within range

Guidance history

Every forecast Harrow put in an earnings release, newest first

Given	Metric	Period	Guidance	Change
Nov 9, 2026	Adjusted EBITDA	Q4 FY2026	$33.00M	New
Nov 9, 2026	Adjusted EBITDA	FY2026	$40.00M	Lowered
Nov 9, 2026	revenue guidance	FY2026	$350.00M – $365.00M	Raised
Aug 10, 2026	Adjusted EBITDA	FY2026	$80.00M – $100.00M	New
Aug 10, 2026	revenue	FY2026	$350.00M – $365.00M	Reaffirmed
May 11, 2026	revenue guidance	FY2026	$350.00M – $365.00M	New
May 11, 2026	revenue	Q2 FY2026	$71.00M – $81.00M	New
Mar 2, 2026	Adjusted EBITDA	FY2026	$80.00M – $100.00M	New
Mar 2, 2026	revenue	FY2026	$350.00M – $365.00M	New
Mar 2, 2026	revenue	FY2026	$133.00M – $153.00M	Lowered
Mar 2, 2026	revenue	FY2026	$203.00M – $226.00M	Raised
Feb 2, 2026	revenue guidance	FY2025	$270.00M – $280.00M	New
Aug 11, 2025	revenue	FY2025	$280.00M	Reaffirmed
Aug 11, 2025	quarterly revenues	FY2025	$100.00M	Lowered
May 8, 2025	revenue target	FY2025	$280.00M	Reaffirmed
Mar 27, 2025	revenue guidance	FY2025	$280.00M	Reaffirmed
Mar 17, 2025	revenue	FY2025	$280.00M	New
May 13, 2024	revenue guidance	FY2024	$180.00M	New
Nov 13, 2023	Adjusted EBITDA	FY2023	$36.00M – $41.00M	Lowered
Nov 13, 2023	revenues	FY2023	$129.00M – $136.00M	Lowered
Nov 13, 2023	revenues	FY2024	$180.00M	New
May 11, 2023	adjusted EBITDA	FY2023	$44.00M – $50.00M	New
May 11, 2023	net revenues	FY2023	$135.00M – $143.00M	New

Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.